Tony Hunt
Chief Executive Officer en REPLIGEN CORPORATION .
Fortuna: 34 M $ al 31/03/2024
Perfil
En la actualidad, Tony J. Hunt es Presidente, Director General y Director de Repligen Corp. Anteriormente, el Sr. Hunt ocupó el cargo de Director Principal de Programas Farmacéuticos en Applied Biosystems, Inc. y Presidente de Bioproducción en Life Technologies Corp. Tony J. Hunt se licenció y se graduó en la Universidad Nacional de Irlanda y obtuvo un MBA en la Questrom School of Business.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
REPLIGEN CORPORATION
0.33% | 18/03/2024 | 183 249 ( 0.33% ) | 34 M $ | 31/03/2024 |
908 DEVICES INC.
0.03% | 04/03/2024 | 8 886 ( 0.03% ) | 67 089 $ | 31/03/2024 |
Cargos activos de Tony Hunt
Empresas | Cargo | Inicio |
---|---|---|
REPLIGEN CORPORATION | Chief Executive Officer | 21/05/2015 |
908 DEVICES INC. | Director/Board Member | 02/03/2022 |
Antiguos cargos conocidos de Tony Hunt.
Empresas | Cargo | Fin |
---|---|---|
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Corporate Officer/Principal | 01/01/2014 |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Corporate Officer/Principal | 01/01/2008 |
Formación de Tony Hunt.
National University of Ireland | Graduate Degree |
Questrom School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
REPLIGEN CORPORATION | Health Technology |
908 DEVICES INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Tony Hunt